YTHDF2 and neoplasm: Phosphoinositide-3-kinase catalytic beta (PI3KCB), a catalytic subunit of PI3K, was reported to be modified by m6A resulting in its degradation, which was caused by YTHDF2, and subsequently inhibited the activation of PI3K/AKT signaling pathway to limit tumor progression (Fig. 4A) [57].